Performance Characteristics of Six Intact Parathyroid Hormone Assays

La'ulu, Sonia L.; Roberts, William L.
December 2010
American Journal of Clinical Pathology;Dec2010, Vol. 134 Issue 6, p930
Academic Journal
The aim of this study was to evaluate the performance characteristics of 6 intact parathyroid hormone assays: Access 2 (Beckman Coulter, Fullerton, CA), ARCHITECT i2000SR (Abbott Diagnostics, Abbott Park, IL), ADVIA Centaur (Siemens Healthcare Diagnostics, Deerfield, IL), Modular E170 (Roche Diagnostics, Indianapolis, IN), IMMULITE 2000 (Siemens Healthcare Diagnostics), and LIAISON (DiaSorin, Stillwater, MN). Sample collection tubes and storage conditions were compared. Imprecision studies were performed using commercial quality control materials. Linearity was assessed using pools prepared from samples. For method comparison, serum and EDTA plasma samples were tested by all methods, and the ARCHITECT was used as the comparison method. Reference intervals were determined using various vitamin D cutoffs. The types of collection tubes and storage conditions are more important for some methods than others. Total coefficients of variation were 10.9% or less. The maximum deviation from the target recovery for linearity ranged from 5.0% to 82.2%. Bland-Altman plots demonstrated percentage biases ranging from -36.3% to 24.4%. The lower limit of the reference interval was not influenced by vitamin D status, whereas the upper reference limit was affected.


Related Articles

  • Diurnal variations in the plasma concentration of parathyroid hormone in dogs. López, I.; Aguilera-Tejero, E.; Estepa, J. C.; Bas, S.; Mayer-Valor, R.; Jiménez, A.; Rodríguez, M. // Veterinary Record: Journal of the British Veterinary Association;9/17/2005, Vol. 157 Issue 12, p344 

    The plasma concentrations of parathyroid hormone (PTH), ionised calcium (Ca2+), total calcium, albumin and inorganic phosphorus, and the pH were measured in blood samples obtained from nine dogs during a period of 26 hours. The plasma PTH levels fluctuated slightly during the day, by about 20...

  • Deletion of PTH Rescues Skeletal Abnormalities and High Osteopontin Levels in Klotho-/- Mice. Quan Yuan; Sato, Tadatoshi; Densmore, Michael; Saito, Hiroaki; Schüler, Christiane; Erben, Reinhold G.; Lanske, Beate // PLoS Genetics;May2012, Vol. 8 Issue 5, Special section p1 

    Maintenance of normal mineral ion homeostasis is crucial for many biological activities, including proper mineralization of the skeleton. Parathyroid hormone (PTH), Klotho, and FGF23 have been shown to act as key regulators of serum calcium and phosphate homeostasis through a complex feedback...

  • Parathyroid Hormone.  // Encyclopedic Reference of Molecular Pharmacology;2004, p713 

    A definition of the term "parathyroid hormone" is presented. This hormone is a major regulator of bone metabolism and calcium homeostasis that is stimulated through a decrease in plasma ionized calcium and increases plasma calcium by activating osteoclasts. It also increases renal tubular...

  • IOQPTH.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1230 

    A definition of the acronym "IOQPTH" which refers to intraoperative quick assay of intact parathyroid hormone is presented.

  • Hypocalcaemia, hyperphosphataemia and elevated parathyroid hormone, a difficult differential diagnosis? Fraile-Gómez, Pilar; Blanc, Marc H.; Segurado-Tostón, Óscar; García-Cosmes, Pedro; Tabernero-Romo, José M. // Nefrologia;2014, Vol. 34 Issue 1, p134 

    A letter to the editor is presented commenting on the diagnosis of hypocalcaemia, hyperphosphataemia and elevated parathyroid hormone.

  • Synthetic Human Parathyroid Hormone 1-34 Fragment for Diagnostic Testing. Mallette, Lawrence E. // Annals of Internal Medicine;11/15/88, Vol. 109 Issue 10, p800 

    Reviews the indications for diagnostic parathyroid hormone (PTH) infusion. PTH preparations for use in stimulatory testing; Measurement of immunoreactive parathyroid hormone; Other responses to PTH infusion.

  • Parathyroid hormone withdrawal.  // Reactions Weekly;11/5/2011, Issue 1376, p23 

    The article describes the cases of two patients who acquired skeletal disorders following discontinuation of parathyroid hormone (PTH) replacement therapy for hypoparathyroidism (HPT).

  • PTH and 1.25 vitamin D response to a low-calcium diet is associated with bone mineral density in renal stone formers. Andreas Pasch; Felix J. Frey; Ute Eisenberger; Markus G. Mohaupt; Olivier Bonny // Nephrology Dialysis Transplantation;Aug2008, Vol. 23 Issue 8, p2563 

    Background. Renal calcium stones and hypercalciuria are associated with a reduced bone mineral density (BMD). Therefore, the effect of changes in calcium homeostasis is of interest for both stones and bones. We hypothesized that the response of calciuria, parathyroid hormone (PTH) and 1.25...

  • Therapeutic Prospects for Parathyroid Hormone and Parathyroid Hormone Analogs. Morley, P.; Whitfield, J.F.; Willick, G.E. // Current Medicinal Chemistry - Immunology, Endocrine & Metabolic ;Nov2001, Vol. 1 Issue 3, p269 

    Parathyroid hormone (PTH) is an 84-amino acid peptide produced by the parathyroid glands that regulate calcium homeostasis through actions on the kidney, intestine and bone. PTH's actions are mediated through a family of receptors that activate the adenylyl cyclase and / or phospholipase Cb...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics